Enzyme-blocking treatment reverses chronic pain in preclinical study

Chronic pain affects more than 50 million Americans, yet for decades, treatment options for pain that persists in the absence of inflammation have been limited. Seventy-five percent of these patients, disproportionately women, experience pain…

Continue Reading

News Source: medicalxpress.com